• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.

作者信息

Oepen G, Eisele K, Thoden U, Birg W

出版信息

Pharmacopsychiatry. 1985 Nov;18(6):343-6. doi: 10.1055/s-2007-1017394.

DOI:10.1055/s-2007-1017394
PMID:4089014
Abstract

The influence of Piracetam on Parkinsonism was studied in 18 patients and 18 matched controls. Clinical, visuomotor and psychometric variables were measured. Piracetam improved visuomotor reaction time (RT) and accuracy in 6 mildly affected and tracing time in 6 moderately affected patients, the clinical condition and the organic brain syndrome in all patients investigated. The improvement of the prolonged RT seems to be correlated with bradyphrenia. No drug influence could be observed in the prolonged interhemispheric transfer time. As the mildly affected patients displayed the clearest effect of Piracetam, its administration in early and mild stage of parkinsonism is recommended.

摘要

相似文献

1
Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.
Pharmacopsychiatry. 1985 Nov;18(6):343-6. doi: 10.1055/s-2007-1017394.
2
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
Mov Disord. 1990;5(3):230-4. doi: 10.1002/mds.870050308.
3
A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
J Postgrad Med. 1980 Apr;26(2):116-20.
4
[Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].吡拉西坦对轻度认知障碍和痴呆患者的认知增强作用
Orv Hetil. 2000 May 28;141(22):1189-93.
5
[Cognitive function in alcoholics in a double-blind study of piracetam].[在一项关于吡拉西坦的双盲研究中酗酒者的认知功能]
Lijec Vjesn. 1990 Mar-Apr;112(3-4):111-4.
6
[Course of alcoholic predelirium during treatment with piracetam: results of serial psychometric tests (author's transl)].
Dtsch Med Wochenschr. 1979 Jun 22;104(25):911-4. doi: 10.1055/s-0028-1104013.
7
[Possible uses of nootrophic drugs in clinical psychiatry (author's transl)].
Cesk Psychiatr. 1978 Apr;74(2):52-60.
8
[Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
Ther Ggw. 1977 Aug;116(8):1504-21.
9
[Antiparkinson medication: increasing effectiveness with piracetam].[抗帕金森药物:与吡拉西坦联用提高疗效]
ZFA (Stuttgart). 1980 Jun 20;56(17):1213-6.
10
[Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam].
Minerva Med. 1989 May;80(5):475-82.

引用本文的文献

1
Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.可变剪接的AMPA受体变构调节的多种分子决定因素。
J Neurosci. 2003 Nov 26;23(34):10953-62. doi: 10.1523/JNEUROSCI.23-34-10953.2003.
2
LY404187: a novel positive allosteric modulator of AMPA receptors.LY404187:一种新型的α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体正向变构调节剂。
CNS Drug Rev. 2002 Fall;8(3):255-82. doi: 10.1111/j.1527-3458.2002.tb00228.x.